A Pan-Cyclophilin Inhibitor, CRV431, Decreases Fibrosis and Tumor Development in Chronic Liver Disease ModelsJoseph Kuo, Daren Ure, Michael Bobardt et al.|Journal of Pharmacology and Experimental Therapeutics|2019Cited by 52
The cyclophilin inhibitor CRV431 inhibits liver HBV DNA and HBsAg in transgenic micePhilippe Gallay, Robert T. Foster, Daren Ure et al.|PLoS ONE|2019Cited by 41
The Novel Cyclophilin Inhibitor CPI-431-32 Concurrently Blocks HCV and HIV-1 Infections via a Similar Mechanism of ActionPhilippe Gallay, Robert T. Foster, Daniel J. Trepanier et al.|PLoS ONE|2015Cited by 37
P0890 : Novel cyclophilin inhibitor CPI-431-32 shows broad spectrum antiviral activity by blocking replication of HCV, HBV and HIV-1 virusesPhilippe Gallay, Cosme Ordonez, Udayan Chatterji et al.|Journal of Hepatology|2015Cited by 4
The cyclophilin inhibitor CRV431 prevents both cyclophilin A-HBx complex formation and HBV replicationRobert T. Foster, Philippe Gallay, Daren Ure et al.|Journal of Hepatology|2017Cited by 2